Literature DB >> 3383981

Ifosfamide in advanced head and neck cancer. A phase II study of the Rotterdam Cooperative Head and Neck Cancer Study Group.

J Verweij1, J Alexieva-Figusch, M F de Boer, B Reichgelt, G Stoter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3383981     DOI： 10.1016/0277-5379(88)90318-5

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN： 0277-5379


× No keyword cloud information.
  3 in total

Review 1.  Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer.

Authors:  K L Dechant; R N Brogden; T Pilkington; D Faulds
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

Review 2.  Head and neck cancer: guidelines for chemotherapy.

Authors:  G Catimel
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

3.  Ifosfamide in advanced epidermoid head and neck cancer.

Authors:  M Martín; E Diaz-Rubio; J L González Larriba; A Casado; J Sastre; J M López-Vega; J Almenarez; S Dominguez
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.